Page 321 - HIVMED_v21_i1.indb
P. 321
Page 7 of 7 Original Research
The weakness of the study was the use of cross-sectional Disclaimer
study design that prevents long-term follow-up of The views and opinions expressed in this article are those of
participants and the absence of ‘hard’ clinical end points – the authors and not necessarily reflect the official policy or
actual BP, glucose monitoring and viral load suppression of
the study cohort over time – to support the contention that position of any affiliated agency of the authors.
the care of this group of Zimbabwean patients is being
compromised. References
1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV & AIDS
Conclusion statistics – 2018 fact sheet [homepage on the Internet]. UNAIDS; 2018. Available
from: https://www.unaids.org/en/resources/fact-sheet
Findings from this study demonstrate that the observed 2. World Health Organization. Working Group on the inclusion of NCDs in other
programmatic areas: WHO global coordination mechanism on the prevention and
incidence and prevalence of HTN and DM among PLWH in control of non-communicable diseases (Working group 3.1, 2016–2017). Geneva:
Gweru district is a function of the capacity of its healthcare World Health Organization; 2018.
system to screen for and adequately manage NCDs. Given 3. Magodoro IM, Esterhuizen TM, Chivese T. A cross-sectional, facility based study of
comorbid non-communicable diseases among adults living with HIV infection in
the ageing population of PLWH in SSA, coupled with the Zimbabwe. BMC Res Notes. 2016;9(1):379. https://doi.org/10.1186/s13104-016-
2187-z
growing prevalence of NCDs in this group, HIV programmes 4. Mutede BR, Magure T, Gombe NT, Bangure D, Tshimanga M. Prevalence and
require strengthening. While the social and economic factors associated with hypertension among anti-retroviral therapy patients aged
problems of Zimbabwe are dire, this study gives voice to 15 years and above in Makonde District, Zimbabwe, 2012: An analytic cross
sectional study. World J Cardiovasc Dis. 2015;5(9):266. https://doi.org/10.4236/
some of its PLWH. We feel that this is a voice that others need wjcd.2015.59030
to hear too. 5. Smit M, Olney J, Ford NP, et al. The growing burden of non-communicable disease
among persons living with HIV in Zimbabwe. AIDS. 2018;32(6):773. https://doi.
org/10.1097/QAD.0000000000001754
Acknowledgements 6. Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis – HIV co-infection: Policy and
epidemiology in 25 countries in the WHO European region. HIV Med. 2008;
Competing interests 9(6):406–414. https://doi.org/10.1111/j.1468-1293.2008.00567.x
7. Ministry of Health and Child Care (MoHCC). The National Health Strategy for
The authors declare that they have no financial or personal Zimbabwe (2016-2020): Equity and quality in health: leaving no one behind.
Harare: Ministry of Health and Child Care; 2016 [cited no date]. Available from:
relationships that may have inappropriately influenced them https://malariaelimination8.org/wp-content/uploads/2017/02/National%20
in writing this research article. Health%20Strategy%20for%20Zimbabwe%202016-2020.pdf
8. Zimbabwe population-based HIV impact assessment: ZIMPHIA 2015–2016, Final
Report [homepage on the Internet]. ICAP at Columbia University. 2019 [cited 2020 Feb
Authors’ contributions 5]. Available from: https://phia.icap.columbia.edu/wp-content/uploads/2019/08/
ZIMPHIA-Final-Report_integrated_Web-1.pdf
All authors contributed equally to this work. 9. Marshall MN. Sampling for qualitative research. Family Prac. 1996;13(6):522–526.
https://doi.org/10.1093/fampra/13.6.522
10. Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation:
Ethical consideration How many interviews are enough? Qual Health Res. 2017;27(4):591–608. https://
doi.org/10.1177/1049732316665344
Ethical approval for this study was obtained from the University 11. Aschengrau A, Seage GR. Essentials of epidemiology in public health. Sudbury,
Massachusetts: Jones & Bartlett Publishers; 2013.
of KwaZulu-Natal Biomedical Research Ethics Committee 12. Mungati M, Manangazira P, Takundwa L, et al. Factors affecting diagnosis and
(Ethical Clearance Number: BE086/19) and the Ministry of management of hypertension in Mazowe District of Mashonaland Central
Province in Zimbabwe: 2012. BMC Cardiovasc Disord. 2014;14(1):102. https://doi.
Health and Child Care Head office in Harare. Participation in org/10.1186/1471-2261-14-102
the study was voluntary. Written informed consent was sought 13. Peltzer K. Utilization and practice of traditional/complementary/alternative
from potential participants, and confidentiality was maintained medicine (TM/CAM) in South Africa. Afr J Tradit Complemen Altern Med.
2009;6(2):175.
throughout the study by removal of personal identifiers after 14. Chamie G, Kwarisiima D, Clark TD, et al. Leveraging rapid community-based HIV
entry into the electronic database and use of non-identifiable testing campaigns for non-communicable diseases in rural Uganda. PLoS One.
2012;7(8):e43400. https://doi.org/10.1371/journal.pone.0043400
coded numbers. All data were password-protected and stored 15. Chhoun P, Tuot S, Harries AD, et al. High prevalence of non-communicable
in the electronic participant database. diseases and associated risk factors amongst adults living with HIV in
Cambodia. PLoS One. 2017;12(11):e0187591. https://doi.org/10.1371/journal.
pone. 0187591
Funding information 16. Coetzee L, Bogler L, De Neve JW, Bärnighausen T, Geldsetzer P, Vollmer S. HIV,
antiretroviral therapy and non-communicable diseases in sub-Saharan Africa:
The research received funding from University of KwaZulu- Empirical evidence from 44 countries over the period 2000 to 2016. J Int AIDS Soc.
2019;22(7):e25364. https://doi.org/10.1002/jia2.25364
Natal, under PhD research grant.
17. Mc Conalogue D, Nxumalo B, Busawa-la F, Sharp A, Walley J. Implementation of a
non-communicable disease (NCD) screening programme in a rural African HIV
clinic. HIV/AIDS Res Treat Open J. 2017;4(1):32–39.
Data availability statement 18. Patel P, Speight C, Maida A, et al. Integrating HIV and hypertension management
in low-resource settings: Lessons from Malawi. PLoS Med. 2018;15(3):e1002523.
Because of the private nature of the data, data for the study https://doi.org/0.1371/journal.pmed.1002523
will be available only upon request and approval of 19. Pfaff C, Scott V, Hoffman R, Mwagomba B. You can treat my HIV-but can you treat
Authorising Ministry of Health. my blood pressure? Availability of integrated HIV and non-communicable disease
care in northern Malawi. Afr J Prim Health Care Fam Med. 2017;9(1):1–8.
http://www.sajhivmed.org.za 313 Open Access